why choose us

First received: September 23, 2023

Clinical Trial: Nebulised 3% Hypertonic Saline Versus 0.9% Saline for Treating Patients Hospitalized With Acute Bronchiolitis

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Bronchiolitis

Study Type: INTERVENTIONAL


Official Title: Nebulised 3% Hypertonic Saline Versus 0.9% Saline for Treating Patients Hospitalized With Acute Bronchiolitis: Protocol of a Randomized, Double-blind, Multicentre Trial

Brief Summary: Bronchiolitis is an acute viral infection of the lower respiratory tract.It is most commonly caused by respiratory syncytial virus (RSV).Only supportive therapy, including suctioning nasal secretions, water-electrolyte balance maintenance, and oxygen supplementation when needed, is recommended.The inhalation of 3% hypertonic saline is not recommended in bronchiolitis management.However, a recently published meta-analysis revealed that the inhalation of hypertonic saline can reduce the risk of hospitalisation for…

Read more